Keeping an eye on patient privacy
One of our ophthalmologist Members recently contacted us about an unusual request from the police to breach patient confidentiality and privacy....
ECCO 2021 Highlights: Interdisciplinary Roundtable
Following ECCO 2021, Stefan Schreiber, MD, Ph.D., Prof. Dr. Rieke Alten, and president of ECCO Laurent Peyrin-Biroulet, MD, Ph.D. discussed the latest developments and findings in Gastroenterology...
EULAR 2021 Highlights: Interdisciplinary Roundtable
Following EULAR 2021, Prof. Dr. med Gerd Burmester and Prof. Dr. Sebastian Zeissig discussed the latest developments and findings in rheumatology and gastroenterology, and review highlights of the...
Simplifying Management for Patients with Compensated Cirrhosis
Associate Professor Simone Strasser University of Sydney, New South Wales, Australia COVID-19 effects in patients with liver disease Up to 40% of individuals who acquire...
Personalized Crohn’s Disease management: Are we there yet?
Crohn’s disease (CD) is a chronic, relapsing immune system dysfunction that has a significant impact on quality of life. Despite advances in our understanding of the disease pathogenesis in recent...
Therapeutic potential of Bifidobacterium infantis 35624™ (Bifantis®) in irritable bowel syndrome
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterised by abdominal pain or discomfort, and alterations in bowel habit 1,2. It is often associated with other...
MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use
Introduction Polyethylene glycol (PEG)-based laxatives are a mainstay of treatment for constipation. MOVICOL®, the first formulation of PEG3350 plus electrolytes (PEG3350+E) licensed in Europe has...
Specific nutrients, gut microbiota and health – how they are all connected
Professor Udo Herz, Danone Nutricia Early Life Nutrition, Amsterdam, The Netherlands, and Associate Professor of Immunology and Laboratory Medicine, Philipps-University, Marburg, Germany Allergies,...
Intestinal microbiota, prebiotics, probiotics and ferments: reviewing the concepts, the evidence and the clinical applications
Dr Carlos Lifschitz, Consultant, Pediatric Gastroenterology, Hospital Italiano, Buenos Aires, Argentina, and Former Associate Professor of Pediatrics, Baylor College of Medicine, Houston, Texas,...
Essential Knowledge Briefing: Gut Health in Early Life: Implications and Management of Gastrointestinal Disorders
The Essential Knowledge Briefing practical guides under ‘Gut Health in Early Life’ examine gut health during the first 1000 days, a critical period of human development which...
1 2